Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

This publication has 13 references indexed in Scilit:

• Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
  Hepatology, 1998
• Hepatorenal Syndrome
  Seminars in Liver Disease, 1997
• Hepatorenal syndrome
  Digestive Diseases and Sciences, 1996
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
  Hepatology, 1996
• Tealipressin in the treatment of hepatorenal syndrome (HRS): a double blind cross-over study 1H pital Cantonal Universitaire, Geneva, Switzerland, 2INSERM U24, H pital Beaujon, Clichy, France
  Hepatology, 1995
• Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
  Gastroenterology, 1993
• The role of atrial natriuretic peptide (ANP) in chronic liver disease
  Pharmacology & Therapeutics, 1993
• Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate
  The Lancet, 1992
• Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis
  Gastroenterology, 1991
• Potential Role of Increased Sympathetic Activity in Impaired Sodium and Water Excretion in Cirrhosis
  New England Journal of Medicine, 1982